Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
Clinical trial NCT05518578 · RECRUITING
Trial details
- NCT number
- NCT05518578
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-07
- Primary completion
- 2027-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.